LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $219,607 | -18.0% | 3,665 | -1.3% | 0.00% | 0.0% |
| Q2 2023 | $267,780 | +7.0% | 3,714 | +9.2% | 0.00% | 0.0% |
| Q1 2023 | $250,251 | -1.7% | 3,402 | -10.7% | 0.00% | 0.0% |
| Q4 2022 | $254,575 | -16.3% | 3,811 | +8.1% | 0.00% | 0.0% |
| Q3 2022 | $304,000 | -2.3% | 3,527 | +0.9% | 0.00% | 0.0% |
| Q2 2022 | $311,000 | -46.4% | 3,497 | -32.1% | 0.00% | 0.0% |
| Q1 2022 | $580,000 | -39.1% | 5,154 | -16.5% | 0.00% | -50.0% |
| Q4 2021 | $953,000 | +15.4% | 6,173 | +4.1% | 0.00% | 0.0% |
| Q3 2021 | $826,000 | -22.9% | 5,928 | -27.4% | 0.00% | -33.3% |
| Q2 2021 | $1,071,000 | -5.5% | 8,161 | +9.8% | 0.00% | -25.0% |
| Q1 2021 | $1,133,000 | +64.4% | 7,430 | +7.2% | 0.00% | +33.3% |
| Q4 2020 | $689,000 | +32.8% | 6,932 | +27.3% | 0.00% | +50.0% |
| Q3 2020 | $519,000 | -17.0% | 5,445 | -2.5% | 0.00% | -33.3% |
| Q2 2020 | $625,000 | +111.9% | 5,584 | +37.6% | 0.00% | +50.0% |
| Q1 2020 | $295,000 | -62.8% | 4,059 | -46.6% | 0.00% | -50.0% |
| Q4 2019 | $793,000 | -8.3% | 7,607 | -12.5% | 0.00% | -20.0% |
| Q3 2019 | $865,000 | -23.9% | 8,690 | -12.8% | 0.01% | -28.6% |
| Q2 2019 | $1,137,000 | -22.9% | 9,964 | -15.0% | 0.01% | -22.2% |
| Q1 2019 | $1,474,000 | -5.1% | 11,728 | +2.5% | 0.01% | -18.2% |
| Q4 2018 | $1,553,000 | -54.5% | 11,442 | -8.1% | 0.01% | -52.2% |
| Q3 2018 | $3,416,000 | +27.7% | 12,445 | -3.6% | 0.02% | +27.8% |
| Q2 2018 | $2,675,000 | +19.4% | 12,912 | -4.9% | 0.02% | +20.0% |
| Q1 2018 | $2,241,000 | +4.7% | 13,571 | -13.1% | 0.02% | 0.0% |
| Q4 2017 | $2,140,000 | +10.9% | 15,625 | +10.3% | 0.02% | -16.7% |
| Q3 2017 | $1,929,000 | +19.7% | 14,170 | +6.8% | 0.02% | +12.5% |
| Q2 2017 | $1,611,000 | +7.2% | 13,271 | -6.6% | 0.02% | 0.0% |
| Q1 2017 | $1,503,000 | -15.8% | 14,204 | -19.1% | 0.02% | -20.0% |
| Q4 2016 | $1,784,000 | +9.6% | 17,562 | +10.1% | 0.02% | -13.0% |
| Q3 2016 | $1,628,000 | -25.2% | 15,956 | -12.6% | 0.02% | -17.9% |
| Q2 2016 | $2,177,000 | +13.3% | 18,249 | +1.8% | 0.03% | +7.7% |
| Q1 2016 | $1,921,000 | -6.9% | 17,934 | -5.7% | 0.03% | +4.0% |
| Q4 2015 | $2,063,000 | +40.4% | 19,026 | +10.9% | 0.02% | +19.0% |
| Q3 2015 | $1,469,000 | -20.2% | 17,157 | -6.0% | 0.02% | -16.0% |
| Q2 2015 | $1,842,000 | +19.1% | 18,252 | -9.0% | 0.02% | +38.9% |
| Q1 2015 | $1,546,000 | +61.9% | 20,048 | +11.7% | 0.02% | +63.6% |
| Q4 2014 | $955,000 | +4.6% | 17,947 | -7.6% | 0.01% | -8.3% |
| Q3 2014 | $913,000 | -37.7% | 19,431 | -17.4% | 0.01% | -36.8% |
| Q2 2014 | $1,465,000 | -36.4% | 23,511 | -31.4% | 0.02% | -34.5% |
| Q1 2014 | $2,305,000 | +317.6% | 34,264 | +226.8% | 0.03% | +262.5% |
| Q4 2013 | $552,000 | -30.8% | 10,485 | -43.1% | 0.01% | -57.9% |
| Q3 2013 | $798,000 | +40.5% | 18,434 | +21.4% | 0.02% | +72.7% |
| Q2 2013 | $568,000 | – | 15,187 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |